纯真的棉花糖
Lv12
100 积分
2024-04-18 加入
-
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a tria
3小时前
已完结
-
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
20小时前
已完结
-
Eosinophils in COPD: are we nearly there yet?
8天前
已完结
-
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
17天前
已完结
-
Benralizumab: for asthma, not yet for COPD
17天前
已完结
-
Dupilumab for COPD with Elevated Eosinophil Counts
17天前
已完结
-
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
17天前
已完结
-
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
17天前
已完结
-
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
17天前
已完结
-
Blood eosinophil counts as a guide for COPD treatment strategies
20天前
已完结